Company Overview of Callaghan Innovation
Callaghan Innovation provides various research and development (R&D) services in New Zealand. The company offers technology and product development services to enhance products or develop new ones; and access to experts to make the right connections to solve technology and business problems in the areas of information and communication technology, manufacturing and design, biotechnologies, measurement standards, sensing and automation, and advanced materials. It also provides a range of programs, training and workshops, such as ImProve that helps businesses to benchmark their management capabilities against international cohorts; Innovation IP, which develops a pragmatic and commercial appro...
55 Featherston Street
Founded in 1992
Key Executives for Callaghan Innovation
General Manager of People & Capability
General Manager of Sectors
General Manager of External Relations
Compensation as of Fiscal Year 2017.
Callaghan Innovation Key Developments
Callaghan Innovation Announces Board Appointments
Sep 11 17
Callaghan Innovation announced two new appointments to its Board, that will provide a new set of skills and business experience. The appointment of Mr. Stefan Korn and Mr. George Gong brings a strong combination of strategic thinking skills and perspective from an investor community Stefan Korn is an experienced entrepreneur, business strategist and investor with over 10 years of experience in managing high growth ventures, early stage investment and software development. He was a member of the Callaghan Innovation Stakeholder Advisory Group, is a founding investor in Lightning Lab. George Gong is an entrepreneur and Angel Investor with rich international business experiences in the Information Technology industry for over twenty years. In 2016 he started Zino Ventures, the first Chinese angel fund in New Zealand.
Mary Quin Resign as CEO of Callaghan Innovation, Effective July 31, 2016
Jul 5 16
Mary Quin resigned as CEO of Callaghan Innovation after three years in the role. She wants flexibility to pursue other professional and personal interests both in New Zealand and overseas and will leave on July 31, 2016.
FrieslandCampina Domo and Glycosyn Enters into Strategic Partnership
Feb 26 16
FrieslandCampina Domo and Glycosyn have entered into a strategic partnership to develop new infant nutrition ingredients. The alliance will leverage Glycosyn's patented technology that is used for the production of oligosaccharides from lactose to manufacture new ingredients for FrieslandCampina's infant formula brand Domo. Under the terms of the agreement, FrieslandCampina Domo will produce and introduce these new ingredients onto the global market.
Similar Private Companies By Industry
Recent Private Companies Transactions
June 27, 2017
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking
Most Searched Private Companies
Sponsored Financial Commentaries